Mingtai Chen

799 total citations
44 papers, 426 citations indexed

About

Mingtai Chen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Mingtai Chen has authored 44 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Mingtai Chen's work include Traditional Chinese Medicine Analysis (10 papers), Traditional Chinese Medicine Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Mingtai Chen is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Traditional Chinese Medicine Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Mingtai Chen collaborates with scholars based in China, Macao and United States. Mingtai Chen's co-authors include Hua Zhou, Mengnan Liu, Guangdong Tong, Yingze Zhao, Guomin Shen, Yi Wang, Fenglin Zhang, Jia Yu, Jun‐Wu Zhang and Xiaoling Liu and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Journal of Ethnopharmacology.

In The Last Decade

Mingtai Chen

39 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingtai Chen China 10 196 107 67 66 62 44 426
Yanfang Yang China 16 264 1.3× 72 0.7× 84 1.3× 48 0.7× 36 0.6× 35 605
Yangyang Wang China 13 218 1.1× 65 0.6× 51 0.8× 29 0.4× 61 1.0× 40 592
Yuanyuan Luo China 11 267 1.4× 54 0.5× 75 1.1× 85 1.3× 72 1.2× 32 562
Dennis Jine-Yuan Hsieh Taiwan 13 201 1.0× 64 0.6× 39 0.6× 73 1.1× 87 1.4× 20 425
Haiyan Sun China 8 242 1.2× 72 0.7× 62 0.9× 25 0.4× 45 0.7× 22 519
Guangdong Tong China 14 219 1.1× 164 1.5× 75 1.1× 29 0.4× 55 0.9× 48 463
Hui Chai China 15 272 1.4× 127 1.2× 79 1.2× 22 0.3× 53 0.9× 20 547
Pei Zhao China 16 315 1.6× 82 0.8× 47 0.7× 145 2.2× 92 1.5× 38 594
Maysa A. Mobasher Saudi Arabia 12 211 1.1× 79 0.7× 46 0.7× 39 0.6× 44 0.7× 32 514

Countries citing papers authored by Mingtai Chen

Since Specialization
Citations

This map shows the geographic impact of Mingtai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingtai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingtai Chen more than expected).

Fields of papers citing papers by Mingtai Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingtai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingtai Chen. The network helps show where Mingtai Chen may publish in the future.

Co-authorship network of co-authors of Mingtai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingtai Chen. A scholar is included among the top collaborators of Mingtai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingtai Chen. Mingtai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Hao, Hao Liu, Ping Liu, et al.. (2025). Programmed cardiomyocyte death in myocardial infarction. APOPTOSIS. 30(3-4). 597–615. 7 indexed citations
3.
4.
De-sheng, XU, Yan Wang, Zirui Li, et al.. (2025). Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation. Pharmacological Research. 215. 107725–107725. 3 indexed citations
5.
Liu, Mengnan, et al.. (2025). Factors associated with higher caregiver burden among informal caregivers of Parkinson’s disease: A systematic review. Medicine. 104(4). e41275–e41275. 1 indexed citations
6.
Liao, Meiyan, Ming Gong, Yuanyuan Li, et al.. (2025). Mitophagy: a novel avenue for herbal medicines alleviating myocardial ischemia/reperfusion injury. APOPTOSIS. 30(11-12). 2676–2693.
7.
He, Jue, Mingtai Chen, Peiying Chen, et al.. (2025). A Mendelian randomization study reveals a causal association between NASH and the risk of atrial fibrillation. Frontiers in Endocrinology. 16. 1390259–1390259.
8.
Mazhar, Maryam, et al.. (2024). Myocardial ischemia-reperfusion injury: The balance mechanism between mitophagy and NLRP3 inflammasome. Life Sciences. 355. 122998–122998. 16 indexed citations
9.
Liu, Hao, et al.. (2024). Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches. International Immunopharmacology. 143(Pt 3). 113562–113562. 6 indexed citations
10.
Chen, Mingtai, Yuanyuan Li, Hao Wu, et al.. (2024). DanShen Decoction targets miR-93-5p to provide protection against MI/RI by regulating the TXNIP/NLRP3/Caspase-1 signaling pathway. Phytomedicine. 135. 156225–156225. 8 indexed citations
11.
Guo, Xin, Yun-Da Yao, Yanyu Zhang, et al.. (2023). Iristectorigenin C suppresses LPS-induced macrophages activation by regulating mPGES-1 expression and p38/JNK pathway. Journal of Ethnopharmacology. 317. 116706–116706. 1 indexed citations
12.
Luo, Gang, Li Chen, Mingtai Chen, et al.. (2023). Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy. Heliyon. 10(1). e23077–e23077. 5 indexed citations
13.
Li, Ziyi, Mengnan Liu, Mingtai Chen, et al.. (2023). Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 18(5). e0284877–e0284877. 8 indexed citations
17.
Liu, Mengnan, Gang Yuan, Gang Luo, et al.. (2022). Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 16 indexed citations
18.
Chen, Mingtai, Mengnan Liu, Jie Zhou, et al.. (2022). Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis. Phytomedicine. 104. 154243–154243. 9 indexed citations
19.
Liu, Mengnan, Jie Xu, Mingtai Chen, et al.. (2022). Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs. Pharmacological Research. 185. 106515–106515. 18 indexed citations
20.
Zhou, Peng, et al.. (2022). Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxide. Phytomedicine. 104. 154305–154305. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026